Xenetic Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xenetic Biosciences, Inc. on July 1, 2015, covering the event date of June 25, 2015. The filing addresses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. However, it notes that the audit reports for the fiscal years ended December 31, 2014, and 2013 contained an uncertainty regarding the Company's ability to continue as a going concern.
Material Changes
- Accountant Dismissal: On June 25, 2015, Ernst and Young LLP was dismissed as the Company's independent registered public accounting firm.
- New Appointment: Marcum LLP was appointed as the new independent registered public accountant.
- Approval: The change was approved by unanimous written consent of the Board of Directors.
- Disagreements: There were no disagreements with the former accountant regarding accounting principles, practices, or auditing scope during the fiscal years 2013-2014 or the interim period ended May 31, 2015.
- Reportable Events: No material weaknesses in internal controls were reported by management as of March 31, 2015. No other reportable events occurred during the specified periods.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the previously disclosed going concern uncertainty. The Company confirmed it did not consult the new accountant regarding accounting principles or matters that were subjects of disagreement prior to retention.
Investor Verification Checklist
- Verify the letter from Ernst and Young LLP (Exhibit 16.1) to confirm their agreement with the disclosures regarding the dismissal.
- Review the most recent Form 10-Q or 10-K to assess the current status of the "going concern" uncertainty mentioned in the 2014 audit report.
- Confirm the effective date of Marcum LLP's engagement and their initial assessment of the Company's financial reporting.